Background: The aim was to examine the role of alexithymia on therapeu-
Introduction
Alexithymia is thought to reflect a comprehensive deficit in the cognitive processing and regulation of emotions (Sifneos, 1994; Taylor, Bagby, & Parker, 1997) and is characterised by a reduced capacity to identify and verbalise feelings, as well as an externally oriented thinking style marked by a lack of introspection, fantasy, and imagination (Taylor et al., 1997) . Patients with high levels of alexithymia have been found to respond poorly to many standard therapeutic interventions (Krystal, 1979; McCallum, Piper, Ogrodniczuk, & Joyce, 2003; Sifneos, 1975; Taylor et al., 1997) as alexithymic features are believed to undermine the therapeutic process and raise the likelihood of treatment resistance (McCallum et al., 2003; Sifneos, 1972; Taylor et al., 1997) .
However, the empirical evidence to support this proposition has not been consistent (see McGillivray, 2015 for a review). Some studies have shown no significant influence of baseline alexithymia on therapeutic outcome following short-term cognitive-behavioural therapy (CBT; Reese, 2008; Rufer et al., 2010) or more intensive group psychotherapy (Becker-Stoll & Gerlinghoff, 2004; Joyce, Fujiwara, Cristall, Ruddy, & Ogrodniczuk, 2013) , while other studies have reported a relationship between high baseline alexithymia and greater depression severity (Özsahin, Uzun, Cansever, & Gulcat, 2003) , greater alcohol dependence severity (Stasiewicz et al., 2012) , and poor therapeutic alliance (Cleland, Magura, Foote, Rosenblum, & Kosanke, 2005) . In addition, high levels of alexithymia that persist after treatment have been linked to poor therapeutic outcomes, such as greater anxiety severity (Fukunishi, Kikuchi, Wogan, & Takubo, 1997) and less improvement in interpersonal problems during treatment (Ogrodniczuk, Sochting, Piper, & Joyce, 2012) .
Given the potential role of alexithymia as an obstacle to therapeutic success and relapse prevention, there is also growing interest in examining the extent to which alexithymia may be modified as a result of therapy. Assessing change in alexithymia has typically been approached in two ways: by assessing mean-level stability, where the average alexithymia score of a whole group is examined over time; and relative stability, where relative differences among individuals' alexithymia scores are examined over time (Mikolajczak & Luminet, 2006 ). Analysis of mean-level stability provides a general indication of change in alexithymia at a group level. However, this method does not provide detailed information of change in alexithymia at an individual level, such as whether patients' scores are roughly changing by the same amount. Personality researchers have argued that mean-level change is commonly observed in personality traits in addition to relative stability (Allemand, Steiger, & Hill, 2013; Skodol, 2008) .
A number of studies have shown high degrees of relative stability in alexithymia scores following therapeutic intervention in addition to significant mean-level declines (e.g., Grabe et al., 2008; Luminet, Bagby, & Taylor, 2001; Rufer et al., 2010; Speranza, Loas, Wallier, & Corcos, 2007) , which is consistent with findings of relative stability and mean-level change in other personality traits, such as neuroticism and extraversion (Santor, Bagby, & Joffe, 1997) . Luminet et al. (2001) have argued that the relative stability of alexithymia should be examined in the context of acute change in clinical symptoms as this would provide stronger evidence to support alexithymia as a personality trait rather than a statedependent phenomenon that fluctuates alongside symptom distress for example. Indeed, many studies have found relative stability in alexithymia scores alongside acute change in clinical symptoms (e.g., de Timary, Luts, Hers, & Luminet, 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello, Porcelli, Grilletti, & Bellomo, 2005) . Cameron, Ogrodniczuk, and Hadjipavlou (2014) conducted a review of studies examining changes in alexithymia following psychological intervention and concluded that alexithymia was partly modifiable. Interestingly, they found more consistent reductions in alexithymia scores across studies that employed interventions specifically designed to target alexithymic features compared to studies measuring change in alexithymia incidentally to change in clinical symptoms following intervention. They concluded that meaningful improvement in alexithymic features may occur alongside, but not be dependent on, other symptomatic changes.
In sum, information about the influence of alexithymia on therapeutic outcome remains contentious due to inconsistent findings across the literature as well as a shortage of research into whether the extent to which alexithymia can be modified plays a role in therapeutic success. Therefore, we consider that in order to determine the impact of alexithymia on therapeutic outcome, while considering different forms of stability, further research is required. Furthermore, the idea that alexithymia undermines the therapeutic process requires additional examination because the relevance of alexithymia as a risk factor in the maintenance of psychiatric illness relies on the value of alexithymia as a predictor of therapeutic outcome.
Most previous studies examining the role of alexithymia in therapy have involved individual therapeutic interventions. However, group therapy has been considered an effective format for patients with alexithymia as groups provide a supportive environment for patients to maximise their opportunity to learn about emotions through a wide range of interpersonal situations (ApfelSavitz, Silverman, & Bennett, 1977; Swiller, 1988) . Patients with alexithymia have also been shown to prefer group therapy compared to individual therapy (Ogrodniczuk, Piper, Joyce, & Abbass, 2009) , which may enhance their engagement in treatment and improve therapeutic outcomes.
Within the context of a group therapy program, the present study examined whether alexithymia interfered with symptom relief over the course of treatment, the extent to which alexithymia changed over the course of treatment, and whether this change in alexithymia accompanied change in psychological distress over the 38 course of treatment. Alexithymia scores before treatment were not expected to predict change in psychological distress severity over the course of cognitive-behavioural group therapy. In line with the literature, a small meanlevel reduction in alexithymia was expected and the association between alexithymia before and after therapy was expected to be relatively large independent of change in psychological distress. Finally, greater change in alexithymia scores was expected to occur alongside greater change in psychological distress scores over the course of therapy.
Method Participants and Procedure
The present study drew data from an outpatient mental health facility linked to a tertiary hospital in Perth, Western Australia. Both the Faculty of Computing Health and Science Ethics Committee at the home University and the ethics committee of the tertiary hospital granted approval for the present research. The sample comprised 61 psychiatric outpatients with an age range from 19 to 66 years (M = 42.40 years, SD = 12.45 years) and comprised 47 (77.0%) female patients. Hospital psychiatrists relied on the International Classification of Mental and Behavioural Disorders (ICD-10; World Health Organization, 2010) for diagnostic purposes. The diagnostic details of the sample were as follows: mood (affective) disorders (54.1%); neurotic, stress-related, and somatoform disorders (19.7%); disorders of adult personality and behaviour (14.8%); schizophrenia, schizotypal, and delusional disorders (9.8%); and behavioural syndromes associated with physiological disturbances and physiological factors (1.6%). Thirty-three patients (54.1%) were identified as alexithymic (according to TAS-20 cut-off scores ≥61, see Taylor et al., 1997) . Many patients had been prescribed psychotropic medication as part of their ongoing treatment. They had also experienced a diverse treatment history, ranging from one inpatient hospitalisation to numerous hospitalisations and/or ongoing private treatment. Only patients who did not require inpatient care or major adjustments to their medication and who were free of alcohol or substance misuse were eligible for the outpatient program.
All patients completed alexithymia and psychological distress scales on the first day (time 1) and last day (time 2) of each therapy group. Some patients had attended more than one therapy group and completed additional scales. Therefore, in order to control for the possible confound of a cumulative treatment effect, only the first alexithymia and psychological distress scales from a patient's earliest therapy group were retained for use in the present study.
Measures
All patients completed the routinely administered 20-item Toronto Alexithymia Scale (TAS-20) and the 42-item Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 1995) , as well as a demographic questionnaire and a consent form for the data to be used in research.
Alexithymia
The TAS-20 (Bagby, Parker, & Taylor, 1994 ) is a selfreport questionnaire designed to measure alexithymia as a personality trait. Participants respond on a 5-point Likert type rating scale for each of the 20 items, from 1 (strongly disagree) to 5 (strongly agree). Each item corresponds to one of three factors associated with the TAS-20: difficulties identifying feelings and distinguishing feelings from bodily sensations of emotional arousal (DIF, factor 1), difficulties describing feelings to others (DDF, factor 2), and externally oriented thinking (EOT, factor 3). Three factor scores and a total score can be calculated. The TAS-20 is the most well-established and widely used instrument to measure alexithymia, with evidence of high internal consistency (α > .79, Bagby et al., 1994; α > .77, Meganck, Vanheule, & Desmet, 2008) , as well as adequate test-retest reliability, construct validity, and criterion validity (Bagby et al., 1994; Parker, Taylor, & Bagby, 2003) . In the present study, the TAS-20 scale demonstrated good internal reliability (α = .81) and the separate factors demonstrated acceptable (EOT, α = .63) to good internal reliability (DIF, α = .87; DDF, α = .76).
Psychological Distress
The DASS-42 (Lovibond & Lovibond, 1995 ) is a selfreport questionnaire designed to measure symptoms of depression, anxiety, and stress. Participants respond on a 4-point Likert type rating scale, where response options range from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time). The DASS yields three scale scores for depression, anxiety, and stress as well as a total composite score, which measures negative emotional symptoms (Sinclair et al., 2012 ; The University of New South Wales, 2013) and has been interpreted as reflecting negative affectivity or psychological distress (Lozano, 2010; Page, Hooke, & Morrison, 2007; Willemsen, Markey, Declercq, & Vanheule, 2011) . The DASS is found to have good reliability for depression (α = .95), anxiety (α = .90), and stress (α = .93) (Crawford & Henry, 2003) and to be a valid and reliable measure for psychiatric populations (Page et al., 2007) . In the present study, the total DASS demonstrated good internal reliability (α = .97) and the separate scales demonstrated good internal reliability (depression, α = .96; anxiety, α = .89; stress α = .97).
Therapy
The outpatient mental health facility offered an integrated group therapy program to assist patients to recover from a variety of mental health problems. As part of the induction process, staff at the facility conducted interviews with new patients to help determine their suitability to group therapy and allocation to a specific therapy group. The facility promoted a transdiagnostic approach to treating mental health problems and consequently group therapy suitability and allocation to specific groups was based on a patient's current needs and expectations, their most pressing difficulty, and availability, rather than diagnosis.
Two clinical staff from various disciplines, including clinical psychology, social work, occupational therapy, and psychiatric nursing facilitated the groups. Each group included approximately 5-12 patients. Each group ran for 2 hr over an average of 8 weeks (min = 4, max = 10). The theoretical approach to the program at the facility was predominately guided by cognitivebehavioural theory. The assortment of groups had different therapeutic strategies (all CBT-based) and focused on themes such as mood management, anxiety management, recovery from depression, self-esteem and assertiveness, anger management, and healthy relationships.
Statistical Analysis
Bivariate correlations were calculated to examine associations between all variables under consideration. A paired samples t-test was used to examine differences in psychological distress scores at time 1 and time 2. A hierarchical regression was conducted to predict change in psychological distress (i.e., DASS scores at time 1 minus DASS scores at time 2) based on alexithymia at time 1 and change in alexithymia while controlling for psychological distress at time 1. Psychological distress change score served as the criterion variable. In the first step, alexithymia at time 1 was the predictor variable. In the second and third steps, psychological distress at time 1 and alexithymia change score were added as additional predictor variables, respectively. In order to examine mean-level change in alexithymia over time, a paired samples t-test was performed, comparing alexithymia scores at time 1 and time 2. Bivariate test-retest correlation was used to examine the relative stability of alexithymia scores from time 1 to time 2. In order to estimate the relative stability of alexithymia while controlling for change in psychological distress severity, a hierarchical regression was conducted. Alexithymia change score served as the criterion variable (i.e., TAS-20 scores at time 1 minus TAS-20 scores at time 2). In the first step, psychological distress at time 1 was the predictor variable. In the second step, alexithymia at time 1 was added as an additional predictor variable. In the third step, psychological distress change score was added as an additional predictor variable. Guidelines by Cohen (1988) were used to interpret effect sizes. All data were analysed using SPSS version 19.0.
Results

Preliminary Analyses
A moderate positive and significant correlation was found between alexithymia at time 1 and psychological distress at time 1, r(61) = .48, p < .001, but no significant correlation between alexithymia at time 1 and psychological distress at time 2. Moderate positive and significant correlations were found between alexithymia at time 2 and psychological distress at time 1, r(61) = .32, p = .011, and time 2 r(61) = .39, p = .002. There was a moderate positive and significant correlation between alexithymia change score and psychological distress change score, r(61) = .42, p = .001. Test-retest correlations showed a very large positive and significant correlation between alexithymia scores across time, r(61) = .74, p < .001, and a moderate positive and significant correlation between psychological distress scores across time r (61) = .47, p < .001 (see Table A1 in Appendix A for bivariate correlations between all variables under examination).
A paired samples t-test showed a significant difference between DASS scores at time 1 (M = 57.23, SD = 28.01) and DASS scores at time 2 (M = 42.98, SD = 21.17), t (60) = 4.27, p < .001, d = .57 (medium effect size).
Given the unexpected non-significant correlation between alexithymia at time 1 and psychological distress at time 2, post-hoc analyses were conducted to determine if the results were the same for each of the subfactors of the TAS-20 (DIF, difficulties identifying feelings and distinguishing feelings from bodily sensations of emotional arousal; DDF, difficulties describing feelings to others; and EOT, externally oriented thinking). DDF at time 1 and EOT at time 1 did not correlate significantly with psychological distress a time 2. Results showed that while a correlation between DIF at time 1 and psychological distress at time 2 was significant, the effect was 40 small, r(61) = .26, p = .04, and this relationship was not significant when the effect of DDF at time 1 was controlled for.
Influence of Alexithymia Across Time on Change in Psychological Distress
Results of a hierarchical regression analysis are presented in Table 1 . In the first step of this regression, alexithymia at time 1 explained a significant 10.1% of the variance in psychological distress change score, F(1, 59) = 6.59, p = .013, f 2 = .11 (small effect size). The addition of psychological distress at time 1 in the second step explained a significant 48.5% of the variance in psychological distress change score, ΔF(1, 58) = 43.23, p < .001, ΔR 2 =
.38 (medium effect size) and alexithymia at time 1 no longer made a significant contribution to the model. Psychological distress at time 1 uniquely explained 38.4% of the variation in psychological distress change score. The addition of alexithymia change score in the third step explained a significant 55.7% of the variance in psychological distress change score, ΔF(1, 57) = 9.26, p = .004, ΔR 2 = .07 (small effect size). Alexithymia change score uniquely explained 7.2% of the variation in psychological distress change score.
Mean-Level Change and Relative Stability of Alexithymia
Results of a paired samples t-test showed a significant difference between alexithymia scores at time 1 (M = 58.98, SD = 13.37) and alexithymia scores at time 2 (M = 56.51, SD = 12.35), t(60) = 2.09, p = .041, d = .19 (small effect size).
Results of bivariate test-retest correlation showed a high degree of relative stability in alexithymia evidenced by a very large positive and significant correlation between alexithymia at time 1 and time 2 (see Preliminary Analysis for result).
Influence of Psychological Distress Across Time on Change in Alexithymia
Results of a hierarchical regression analysis are presented in Table 2 . In the first step of this regression, psychological distress at time 1 explained a significant 7.3% of the variance in alexithymia change score, F(1, 59) = 4.65, p = .035, f 2 = .08 (small effect size). The addition of alexithymia at time 1 in the second step explained a significant 20.8% of the variance in alexithymia change score, ΔF(1, 58) = 9.88, p = .003, ΔR 2 = .13 (small effect size)
and psychological distress at time 1 no longer made a significant contribution to the model. Alexithymia at time 1 uniquely explained 13.5% of the variation in alexithymia change score. The addition of psychological distress change score in the third step explained a significant 31.9% of the variance in alexithymia change score, ΔF (1, 57) = 9.26, p = .004, ΔR 2 = .11 (small effect size).
Psychological distress change score uniquely explained 11.1% of the variation in alexithymia change score.
Discussion
The overarching purpose of the present study was to investigate the role of alexithymia on therapeutic outcome following cognitive-behavioural group therapy. Specifically, we examined the influence of alexithymia on psychological distress severity over the course of treatment; the extent to which alexithymia can be modified through treatment, in the context of a reduction in psychological distress; and the influence of change in alexithymia on change in psychological distress over the course of treatment. While baseline alexithymia was found to influence therapeutic outcome, as it was a significant predictor of Note. β = standardised coefficient; outcome variable was psychological distress change score; multicollinearity was not considered a problem (tolerance level for each predictor was >0.65).
psychological distress change score, the effect was lost when baseline psychological distress was accounted for. In addition, the correlation between alexithymia score at time 1 and psychological distress score at time 2 was not significant. These results suggest that a reduced capacity to recognise and communicate one's feelings does not hinder the effectiveness of short-term cognitivebehavioural group therapy in reducing symptom distress. This finding is consistent with previous studies that have found baseline alexithymia scores to have no impact on change in clinical symptoms over the course of shortterm CBT (Reese, 2008; Rufer et al., 2010) . The present finding also supports the idea that alexithymia may interfere less with behavioural-based treatments, such as CBT, because treatments that emphasise structured exercises and behavioural recommendations are less anxiety provoking for patients with high alexithymia compared to treatments that primarily rely on emotional awareness and psychological introspection (Lumley, Neely, & Burger, 2007; Rufer et al., 2010) . Overall, a small reduction in alexithymia scores was found from before to after therapy, indicating that alexithymic features can be reduced by using cognitivebehavioural group therapy for the treatment of general psychiatric outpatients. This finding is consistent with previous studies that have found small (Rufer et al., 2004) to medium (Grabe et al., 2008; Ogrodniczuk et al., 2012) reductions in alexithymia following group therapy. The reduction in mean alexithymia scores may have been, in part, dependent on the reduction in clinical severity over the course of treatment, as there was a medium significant correlation between alexithymia and psychological distress change scores. In addition to the small mean-level reduction in alexithymia, a high degree of relative stability in alexithymia scores was observed over the course of treatment. Furthermore, alexithymia scores before treatment were found to make a significant contribution to the prediction of alexithymia change scores over the effects contributed by baseline psychological distress and change in psychological distress severity over the course of treatment. This finding is in line with several previous studies (de Timary et al., 2008; Luminet et al., 2001; Picardi et al., 2012; Todarello et al., 2005) where alexithymia scores before treatment have been found to be the best predictor of alexithymia scores after treatment. In this respect, alexithymia can be compared to other personality traits such as neuroticism and extraversion, which have shown a high degree of relative stability and a lack of mean-level stability over short periods in the presence of change in clinical symptoms (Santor et al., 1997) . The present findings indicate that patients with high alexithymia who enter shortterm cognitive-behavioural group therapy are likely to show persistent difficulties recognising, examining, and communicating their feelings after treatment, despite experiencing a marked decline in psychological distress. However, it should be considered that smaller changes in alexithymia and larger changes in psychological distress would be expected in the present study given that the interventions targeted psychopathology symptoms and not specific features of alexithymia.
The small improvement in patients' awareness and verbalisation of emotion may have contributed to moderate symptom relief over the course of treatment in the present study, as alexithymia change score accounted for a significant, albeit small, amount of variation in psychological distress change score, after controlling for baseline alexithymia and psychological distress. This finding supports previous studies that have found significant associations between reductions in alexithymia over the course of treatment and positive therapeutic outcome (Grabe et al., 2008; Ogrodniczuk et al., 2012; Spek, Nyklί cek, Cuijpers, & Pop, 2008) . Interestingly, while the correlation between baseline alexithymia and psychological distress after treatment was not found to be significant in the present study, there was a significant correlation between alexithymia scores after treatment and psychological distress scores after treatment. Taken Note. β = standardised coefficient; outcome variable was alexithymia change score; multicollinearity was not considered a problem (tolerance level for each predictor was >0.44).
together, these results could indicate that as patients gained a clearer understanding of their emotions during group therapy they were able to respond more accurately on the psychological distress scale once treatment had finished. The present study had several limitations. The sample size was not large enough to investigate whether the varied lengths of therapy across the different groups influenced the relationship between alexithymia and therapeutic intervention. A lack of control group meant that we cannot definitively attribute changes in alexithymia and psychological distress to treatment effects rather than time. The present findings were also delimited by the method of data collection: since the data were archival, a number of variables could not be controlled, including the number or types of concomitant treatments patients received, the psychometric scale used to assess therapeutic outcome, and the timing at which the scales were administered. Lastly, accuracy in the assessment of measuring change in personality would be improved by the use of a multiple method approach (Caretti et al., 2011; Eid & Diener, 2006) , rather than reliance on a single method approach, such as a 5-point Likert type rating scale (Heatherton & Nichols, 1994) . Accuracy in the assessment of the alexithymia construct specifically may have been limited by the exclusive use of a self-report questionnaire, particularly given only moderate correlations between the TAS-20 and observer-rated measures such as the Toronto Structured Interview for Alexithymia (e.g., Inslegers et al., 2013) .
In conclusion, baseline alexithymia was not found to impede group therapy outcome over the course of treatment after controlling for baseline psychological distress. Alexithymic features were reduced following cognitivebehavioural group therapy for the treatment of general psychiatric outpatients. However, the reduction was small and a high degree of relative stability in alexithymia scores was observed, independent of symptom relief, which supports the suggestion that alexithymia is a personality trait and indicates that patients with high levels of alexithymia at baseline may experience ongoing difficulties identifying, communicating, and examining their feelings after treatment. As change in alexithymia accompanied change in psychological distress over the course of treatment it is likely that as patients improve their ability to identify and articulate emotion they gain some symptom relief. Therefore, modifying alexithymia may pose a therapeutic advantage and reduce patients' risk of experiencing residual clinical symptomatology once treatment has ended. However, future research will need to examine the directionality and/or mechanisms of this change. The highlighted limitations restrict our ability to generalise our findings and more randomised controlled trials are required in future research, however, clinical features upon which the present research was based could complement laboratory research designs, and contribute important information likely to be found by therapists in clinical settings.
